{
    "code": "52027865",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027865",
    "time": "2022-10-28 03:52:20",
    "許可證字號": "衛部藥輸字第027865號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/05\/21",
    "發證日期": "109\/05\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202786502",
    "中文品名": "羅思克200毫克膠囊",
    "英文品名": "Rozlytrek 200mg hard capsules",
    "適應症": "1.ROS1陽性之非小細胞肺癌：適用於治療ROS1陽性之局部晚期或轉移性非小細胞肺癌的成人病人。\r\n2.NTRK基因融合陽性之實體腫瘤：適用於治療NTRK基因融合陽性之實體腫瘤的成人及12歲(含)以上小兒病人，並應符合以下條件：\r\n(1)具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation)，\r\n(2)為轉移性實體腫瘤，或手術切除極可能造成嚴重病狀(severe morbidity)，\r\n(3)於治療後發生疾病惡化，或沒有合適的替代治療選項。",
    "劑型": "130膠囊劑",
    "包裝": "6-1000顆瓶裝HDPE瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/05\/21",
    "主成分略述": "Entrectinib",
    "限制項目": "02輸　入 1S須執行確認性療效臨床試驗 5F免除銜接性試驗",
    "申請商名稱": "1901701100  羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FUS1056000  Mayne Pharma Inc.",
            "製造廠廠址": "1240 Sugg Parkway Greenville, NC 27834 ,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0208000  F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013007800",
            "成分名稱": "Entrectinib",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Rozlytrek_Chinese PI_200 mg-110-12-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027865&Seq=002&Type=9"
        },
        {
            "title": "Rozlytrek 200 mg_Label_027865-1-LAB-01-109-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027865&Seq=002&Type=8"
        },
        {
            "title": "Rozlytrek 200 mg_FB_027865-1-CTN-01-109-05-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027865&Seq=001&Type=8"
        }
    ]
}